Clinical Trials Browser

Leukemia, Lymphocytic, Chronic, B-Cell × duvelisib × 90 days × Clear all

NCT03534323 2026-03-23

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

Phase 1/2 Active not recruiting

55 enrolled 14 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell